臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"wu s g"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 46-95 of 224 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-06-30T08:46:37Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.;Tsai M.-F.;Gow C.-H.;Wu S.-G.;Liu Y.-N.;Chang Y.-L.;Yu S.-L.;Hsing-Chen Tsai;Lin S.-W.;Chen Y.-W.;Kuo P.-Y.;Yang P.-C.;Shih J.-Y.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; HSING-CHEN TSAI; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2021-05-02T03:49:15Z	The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation	Wu S.-G.;Yu C.-J.;Yang J.C.-H.;Jin-Yuan Shih; Wu S.-G.; Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH
臺大學術典藏	2021-05-02T03:49:14Z	An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan	Wu S.-G.;Chiang C.-L.;Liu C.-Y.;Wang C.-C.;Su P.-L.;Hsia T.-C.;Jin-Yuan Shih;Chang G.-C.; Wu S.-G.; Chiang C.-L.; Liu C.-Y.; Wang C.-C.; Su P.-L.; Hsia T.-C.; JIN-YUAN SHIH; Chang G.-C.
臺大學術典藏	2021-05-02T03:49:13Z	miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-�eB Pathway	Liu Y.-N.;Tsai M.-F.;Wu S.-G.;Chang T.-H.;Tsai T.-H.;Gow C.-H.;Wang H.-Y.;Jin-Yuan Shih; Liu Y.-N.; Tsai M.-F.; Wu S.-G.; Chang T.-H.; Tsai T.-H.; Gow C.-H.; Wang H.-Y.; JIN-YUAN SHIH
臺大學術典藏	2021-05-02T03:49:11Z	Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1	Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; JIN-YUAN SHIH; Chang Y.-L.; Yu C.-J.
臺大學術典藏	2021-05-02T03:29:25Z	The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation	Wu S.-G.;Chong-Jen Yu;Yang J.C.-H.;Shih J.-Y.; Wu S.-G.; CHONG-JEN YU; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏	2021-05-02T03:29:21Z	Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1	Chung K.-P.; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; CHONG-JEN YU
臺大學術典藏	2021-04-23T05:56:32Z	The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation	Wu S.-G.;Yu C.-J.;Chih-Hsin Yang;Shih J.-Y.; Wu S.-G.; Yu C.-J.; CHIH-HSIN YANG; Shih J.-Y.
臺大學術典藏	2021-03-19T06:57:51Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; YEUN-CHUNG CHANG; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:46Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y.;Wu S.-G.;Yang C.-H.;Chang Y.-L.;Yeun-Chung Chang;Hsu Y.-C.;Shih J.-Y.;Yang P.-C.; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; YEUN-CHUNG CHANG; Hsu Y.-C.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-03-19T06:57:39Z	Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis	Wu S.-G.;Hu F.-C.;Chang Y.-L.;Lee Y.-C.;Yu C.-J.;Yeun-Chung Chang;Wu J.-Y.;Shih J.-Y.;Yang P.-C.; Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; YEUN-CHUNG CHANG; Wu J.-Y.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-03-13T03:29:30Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	YEN-FU CHEN; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.
臺大學術典藏	2021-03-13T03:29:28Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	YEN-FU CHEN; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2021-03-12T00:50:59Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.;Yu C.-J.;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;I-Shiow Jan;Yang P.-C.;Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; I-SHIOW JAN; Yang P.-C.; Shih J.-Y.
臺大學術典藏	2021-02-05T07:26:14Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	KUEI-PIN CHUNG; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2021-02-05T07:26:09Z	Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1	Kuei-Pin Chung;Huang Y.-L.;Chen Y.-J.;Juan Y.-H.;Hsu C.-L.;Nakahira K.;Huang Y.-T.;Lin M.-W.;Wu S.-G.;Shih J.-Y.;Chang Y.-L.;Yu C.-J.; KUEI-PIN CHUNG; Huang Y.-L.; Chen Y.-J.; Juan Y.-H.; Hsu C.-L.; Nakahira K.; Huang Y.-T.; Lin M.-W.; Wu S.-G.; Shih J.-Y.; Chang Y.-L.; Yu C.-J.
臺大學術典藏	2021-01-05T00:56:38Z	Acute cytomegalovirus pneumonitis in patient with lymphomatoid granulomatosis	Wu S.-G.; Tsai T.-H.; SHANG-JU WU
臺大學術典藏	2020-12-29T05:33:28Z	Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection	Yang P.-C.; Kuo P.-H.; HSIN-YUN SUN; Wu J.-Y.; Wu S.-G.
臺大學術典藏	2020-12-02T02:34:38Z	Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation	Wu S.-G.;Shih J.-Y.;Yu C.-J.;Pan-Chyr Yang; Wu S.-G.; Shih J.-Y.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:34Z	Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response	Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Chang Y.-L.;Yu C.-J.;Shin J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:33Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Wu S.-G.; Gow C.-H.; Yu C.-J.; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:31Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu J.-Y.; Yu C.-J.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:29Z	Good response to gefitinib in lung adenocarcinoma of complex epidermal growth factor receptor (EGFR) mutations with the classical mutation pattern	Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Chang Y.-L.; Hsu Y.-C.; Wu J.-Y.; Yang C.-H.; Yu C.-J.; Tsai M.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:24Z	Critical illness polyneuromyopathy in a patient with disseminated cryptococcal infection	Wu J.-Y.; Wu S.-G.; Sun H.-Y.; Kuo P.-H.; Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Sun H.-Y.; Kuo P.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:23Z	Successful weaning after plasma exchange for polyneuropathy related to POEMS syndrome	Wu S.-G.; Kuo P.-H.; Pan-Chyr Yang; Wu S.-G.; Kuo P.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:10Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y.;Wu S.-G.;Yang C.-H.;Chang Y.-L.;Chang Y.-C.;Hsu Y.-C.;Shih J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:09Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Pan-Chyr Yang; Wu S.-G.; Yang C.-H.; Yu C.-J.; Lee J.-H.; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:04Z	Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma	Tsai T.-H.; Wu S.-G.; Chang Y.-L.; Wu C.-T.; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:34:03Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Wu S.-G.; Kuo Y.-W.; Chang Y.-L.; Shih J.-Y.; Chen Y.-H.; Tsai M.-F.; Yu C.-J.; Yang C.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:34:01Z	RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer	Tsai T.-H.; Su K.-Y.; Wu S.-G.; Chang Y.-L.; Luo S.-C.; Jane I.-S.; Yu C.-J.; Yue S.-L.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:59Z	Clinical outcomes in non-small cell lung cancers harboring different exon 19 deletions in EGFR	Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; Pan-Chyr Yang; Chung K.-P.; Wu S.-G.; Wu J.-Y.; Yang J.-H.; Yu C.-J.; Wei P.-F.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:52Z	Frequent EGFR mutations in nonsmall cell lung cancer presenting with miliary intrapulmonary carcinomatosis	Wu S.-G.; Hu F.-C.; Chang Y.-L.; Lee Y.-C.; Yu C.-J.; Chang Y.-C.; Wu J.-Y.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:49Z	Survival of lung adenocarcinoma patients with malignant pleural effusion	Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; PAN-CHYR YANG; Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:45Z	Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations	Chen Y.-F.;Hsieh M.-S.;Wu S.-G.;Chang Y.-L.;Shih J.-Y.;Liu Y.-N.;Tsai M.-F.;Tsai T.-H.;Yu C.-J.;Yang J.C.-H.;PAN-CHYR YANG; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:39Z	Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer	Lin Y.-T.;Wang Y.-F.;Yang J.C.-H.;Yu C.-J.;Wu S.-G.;Shih J.-Y.;Pan-Chyr Yang; Lin Y.-T.; Wang Y.-F.; Yang J.C.-H.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:29Z	EGFR-L858R mutant enhances lung adenocarcinoma cell invasive ability and promotes malignant pleural effusion formation through activation of the CXCL12-CXCR4 pathway	Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; Pan-Chyr Yang; Shih J.-Y.; Tsai M.-F.; Chang T.-H.; Wu S.-G.; Yang H.-Y.; Hsu Y.-C.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:26Z	Efficacy of pemetrexed-based chemotherapy in patients with ROS1 fusion-positive lung adenocarcinoma compared with in patients harboring other driver mutations in East Asian populations	Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; Pan-Chyr Yang; Shih J.-Y.; Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; Yang J.C.-H.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:23Z	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients	Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.; Wu S-G.; Liu Y.-N.; Tsai M.-F.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Yang J.C.-H.; Wen Y.-F.; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:21Z	Association of BIM deletion polymorphism with intrinsic resistance to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma	Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Liu Y.-N.; Yu C.-J.; PAN-CHYR YANG
臺大學術典藏	2020-12-02T02:33:19Z	The role of PIK3CA mutations among lung adenocarcinoma patients with primary and acquired resistance to EGFR tyrosine kinase inhibition	Wu S.-G.; Chang Y.-L.; Yu C.-J.; Pan-Chyr Yang; Shih J.-Y.; Wu S.-G.; Chang Y.-L.; Yu C.-J.; PAN-CHYR YANG; Shih J.-Y.
臺大學術典藏	2020-12-02T02:33:14Z	Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C	Chang T.-H.; PAN-CHYR YANG et al.; Chang T.-H.; Tsai M.-F.; Gow C.-H.; Wu S.-G.; Liu Y.-N.; Chang Y.-L.; Yu S.-L.; Tsai H.-C.; Lin S.-W.; Chen Y.-W.; Kuo P.-Y.; Pan-Chyr Yang; Shih J.-Y.
臺大學術典藏	2020-08-18T07:28:24Z	Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer	Yang J.C.-H.; YU-FEN WANG; Lin Y.-T.; Yu C.-J.; Wu S.-G.; Shih J.-Y.; Yang P.-C.
臺大學術典藏	2020-08-13T06:34:00Z	First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer	Wu J.-Y.; Yu C.-J.; Yang P.-C.; JIN-YUAN SHIH; Wei P.-F.; Hsu Y.-C.; Chang Y.-C.; Gow C.-H.; Yang C.-H.; Wu S.-G.; Chiu Y.-H.
臺大學術典藏	2020-08-13T06:34:00Z	Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma	Wu S.-G.; Gow C.-H.; Yu C.-J.; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; JIN-YUAN SHIH; Lee Y.-C.; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:56Z	Good response to gefitinib in lung adenocarcinoma harboring coexisting EML4-ALK fusion gene and EGFR mutation	Kuo Y.-W.;Wu S.-G.;Ho C.-C.;Jin-Yuan Shih; Kuo Y.-W.; Wu S.-G.; Ho C.-C.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:54Z	Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor	Lin S.-B.; Wu C.-P.; JIN-YUAN SHIH; Yang P.-C.; Lan C.-C.; Yang C.-H.; Yu Y.-L.; Yu S.-L.; Huang C.-P.; Chang T.-H.; Tsai M.-F.; Su K.-Y.; Wu S.-G.
臺大學術典藏	2020-08-13T06:33:53Z	Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations	Chang Y.-L.; JIN-YUAN SHIH; Yang P.-C.; Hsu Y.-C.; Lee J.-H.; Wu S.-G.;Yang C.-H.;Yu C.-J.;Lee J.-H.;Hsu Y.-C.;Chang Y.-L.;Jin-Yuan Shih;Yang P.-C.; Wu S.-G.; Yang C.-H.; Yu C.-J.
臺大學術典藏	2020-08-13T06:33:53Z	Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutations	Wu J.-Y.; Wu S.-G.; Yang C.-H.; Chang Y.-L.; Chang Y.-C.; Hsu Y.-C.; JIN-YUAN SHIH; Yang P.-C.
臺大學術典藏	2020-08-13T06:33:52Z	Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction	Lee Y.-C.; Tsai M.-F.; Wu S.-G.; Chang Y.-L.; Lin J.-W.; Wu C.-T.; Chen H.-Y.; Yu C.-J.; JIN-YUAN SHIH
臺大學術典藏	2020-08-13T06:33:50Z	EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with Wild-type EGFR	Tsai M.-F.; Yu C.-J.; Chen Y.-H.; JIN-YUAN SHIH; Chang Y.-L.; Kuo Y.-W.; Wu S.-G.; Wu S.-G.;Kuo Y.-W.;Chang Y.-L.;Jin-Yuan Shih;Chen Y.-H.;Tsai M.-F.;Yu C.-J.;Yang C.-H.;Yang P.-C.; Yang C.-H.; Yang P.-C.

Showing items 46-95 of 224 (5 Page(s) Totally)
1 2 3 4 5 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 51359166 Online Users : 989 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library